Drugs & Targets FDA Approves Ninlaro and Darzalex For the Treatment of Multiple Myeloma November 30, 2015Vol.38 No.11
Keytruda Shows Anti-Melanoma Activity in Three Combinations and Phase III Trial November 30, 2015Vol.38 No.11
Telotristat Etiprate Demonstrates Clinical Benefit in Phase III Carcinoid Syndrome Study November 03, 2015Vol.38 No.10
Study: Lenvatinib-Everolimus Combination Can Improve PFS in Renal Cell Carcinoma November 03, 2015Vol.38 No.10
Phase III Trial Demonstrates Shorter, Hypofractionated RT Can Deliver Similar Results Compared to Conventional RT November 03, 2015Vol.38 No.10
Patients Receiving IMRT Had Less Toxicity Compared to 3D CRT, Study Finds November 03, 2015Vol.38 No.10
